Page last updated: 2024-08-26

cb 10375 and nsc 262266

cb 10375 has been researched along with nsc 262266 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beijnen, JH; Flora, KP; Halbert, GW; Henrar, RE; Slack, JA	1

Other Studies

1 other study(ies) available for cb 10375 and nsc 262266

Article	Year
CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugs. British journal of cancer, 1995, Volume: 72, Issue:1 Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bryostatins; Chemistry, Pharmaceutical; Drug Stability; Excipients; Imidazoles; Isoquinolines; Lactones; Macrolides; Quaternary Ammonium Compounds; Solubility; Triazines	1995

Article

Year

CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugs.

British journal of cancer, 1995, Volume: 72, Issue:1

Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bryostatins; Chemistry, Pharmaceutical; Drug Stability; Excipients; Imidazoles; Isoquinolines; Lactones; Macrolides; Quaternary Ammonium Compounds; Solubility; Triazines

1995